LOUIS SULLIVAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LOUIS SULLIVAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOUIS SULLIVAN. LOUIS SULLIVAN is Director in HENRY SCHEIN INC ($HSIC) and Director in UNITED THERAPEUTICS Corp ($UTHR) and Director in ANI PHARMACEUTICALS INC ($ANIP) and Director in Emergent BioSolutions Inc. ($EBS).
Latest Insider Trading Transactions of LOUIS SULLIVAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANIP, EBS, HSIC, UTHR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 0.00 | 1,680 | 0 | 0 | |
| Jun 28 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 0.00 | 1,680 | 0 | 11,100 | 9.4 K to 11.1 K (+17.83 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 88.03 | 15,000 | 1,320,450 | 0 | |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 63.90 | 15,000 | 958,500 | 0 | |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 194.30 | 15,000 | 2,914,500 | 9,420 | 24.4 K to 9.4 K (-61.43 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 88.03 | 15,000 | 1,320,450 | 24,420 | 9.4 K to 24.4 K (+159.24 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 194.30 | 15,000 | 2,914,500 | 9,420 | 24.4 K to 9.4 K (-61.43 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 63.90 | 15,000 | 958,500 | 24,420 | 9.4 K to 24.4 K (+159.24 %) |
| May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 18.64 | 10,305 | 192,085 | 0 | |
| May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 61.62 | 3,118 | 192,131 | 39,945 | 43.1 K to 39.9 K (-7.24 %) |
| May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 18.64 | 10,305 | 192,085 | 43,063 | 32.8 K to 43.1 K (+31.46 %) |
| Sep 18 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Gift | G | 0.00 | 10,004 | 0 | 32,758 | 42.8 K to 32.8 K (-23.39 %) |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 15,786 | |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 15,786 | |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.23 | 7,893 | 877,904 | 42,762 | 50.7 K to 42.8 K (-15.58 %) |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.23 | 7,893 | 877,904 | 42,762 | 50.7 K to 42.8 K (-15.58 %) |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 20.08 | 7,893 | 158,491 | 50,655 | 42.8 K to 50.7 K (+18.46 %) |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 20.08 | 7,893 | 158,491 | 50,655 | 42.8 K to 50.7 K (+18.46 %) |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.22 | 20,525 | 2,282,702 | 42,762 | 63.3 K to 42.8 K (-32.43 %) |
| Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.22 | 20,525 | 2,282,702 | 42,762 | 63.3 K to 42.8 K (-32.43 %) |
| Jun 30 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 119.76 | 5,160 | 617,966 | 5,160 | |
| Jun 30 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 1,680 | 0 | 1,680 | |
| Jun 30 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 0.00 | 2,300 | 0 | 9,420 | 7.1 K to 9.4 K (+32.30 %) |
| May 26 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 2,821 | 0 | 63,287 | 60.5 K to 63.3 K (+4.67 %) |
| Mar 27 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 48.11 | 15,000 | 721,650 | 0 | |
| Mar 27 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 90.54 | 15,000 | 1,358,100 | 7,120 | 22.1 K to 7.1 K (-67.81 %) |
| Mar 27 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 48.11 | 15,000 | 721,650 | 22,120 | 7.1 K to 22.1 K (+210.67 %) |
| Mar 24 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 6,000 | 328,620 | 0 | |
| Mar 24 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 83.95 | 6,000 | 503,700 | 7,120 | 13.1 K to 7.1 K (-45.73 %) |
| Mar 24 2020 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 6,000 | 328,620 | 13,120 | 7.1 K to 13.1 K (+84.27 %) |
| Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 13.00 | 7,893 | 102,609 | 0 | |
| Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 14.71 | 7,893 | 116,106 | 0 | |
| Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 58.96 | 7,893 | 465,357 | 60,466 | 68.4 K to 60.5 K (-11.55 %) |
| Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 14.71 | 7,893 | 116,106 | 68,359 | 60.5 K to 68.4 K (+13.05 %) |
| Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 58.96 | 7,893 | 465,357 | 60,466 | 68.4 K to 60.5 K (-11.55 %) |
| Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 13.00 | 7,893 | 102,609 | 68,359 | 60.5 K to 68.4 K (+13.05 %) |
| Jun 28 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
| Jun 28 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 76.36 | 6,310 | 481,832 | 6,310 | |
| Jun 28 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
| Jun 28 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 0.00 | 3,750 | 0 | 5,120 | 1.4 K to 5.1 K (+273.72 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 5,736 | 0 | 60,466 | 54.7 K to 60.5 K (+10.48 %) |
| May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 13.37 | 7,893 | 105,529 | 0 | |
| May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 49.41 | 2,135 | 105,490 | 54,730 | 56.9 K to 54.7 K (-3.75 %) |
| May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 13.37 | 7,893 | 105,529 | 56,865 | 49 K to 56.9 K (+16.12 %) |
| Mar 04 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 8,000 | |
| Mar 04 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 126.84 | 1,000 | 126,840 | 1,370 | 2.4 K to 1.4 K (-42.19 %) |
| Mar 04 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 2,370 | 1.4 K to 2.4 K (+72.99 %) |
| Feb 04 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 9,000 | |
| Feb 04 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 115.83 | 1,000 | 115,830 | 1,370 | 2.4 K to 1.4 K (-42.19 %) |
| Feb 04 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 2,370 | 1.4 K to 2.4 K (+72.99 %) |
| Jan 03 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 10,000 | |
| Jan 03 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 107.65 | 1,000 | 107,650 | 1,370 | 2.4 K to 1.4 K (-42.19 %) |
| Jan 03 2019 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 2,370 | 1.4 K to 2.4 K (+72.99 %) |
| Dec 04 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 11,000 | |
| Dec 04 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 119.53 | 1,000 | 119,530 | 1,370 | 2.4 K to 1.4 K (-42.19 %) |
| Dec 04 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 2,370 | 1.4 K to 2.4 K (+72.99 %) |
| Nov 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 12,000 | |
| Nov 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 115.04 | 1,000 | 115,040 | 1,370 | 2.4 K to 1.4 K (-42.19 %) |
| Nov 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | M | 54.77 | 1,000 | 54,770 | 2,370 | 3.4 K to 2.4 K (-29.67 %) |
| Oct 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 11,000 | |
| Oct 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 125.96 | 1,000 | 125,960 | 3,370 | 4.4 K to 3.4 K (-22.88 %) |
| Oct 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 4,370 | 3.4 K to 4.4 K (+29.67 %) |
| Sep 05 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 12,000 | |
| Sep 05 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 119.45 | 1,000 | 119,450 | 3,370 | 4.4 K to 3.4 K (-22.88 %) |
| Sep 05 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 4,370 | 3.4 K to 4.4 K (+29.67 %) |
| Aug 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 13,000 | |
| Aug 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 116.66 | 1,000 | 116,660 | 3,370 | 4.4 K to 3.4 K (-22.88 %) |
| Aug 02 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 4,370 | 3.4 K to 4.4 K (+29.67 %) |
| Jul 05 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 54.77 | 1,000 | 54,770 | 14,000 | |
| Jul 05 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 113.81 | 1,000 | 113,810 | 3,370 | 4.4 K to 3.4 K (-22.88 %) |
| Jul 05 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 54.77 | 1,000 | 54,770 | 4,370 | 3.4 K to 4.4 K (+29.67 %) |
| Jun 28 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 0.00 | 1,620 | 0 | 0 | |
| Jun 28 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 3,750 | 0 | 3,750 | |
| Jun 28 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 0.00 | 1,620 | 0 | 3,370 | 1.8 K to 3.4 K (+92.57 %) |
| Jun 06 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 51.77 | 15,000 | 776,550 | 0 | |
| Jun 06 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 108.50 | 15,000 | 1,627,500 | 1,750 | 16.8 K to 1.8 K (-89.55 %) |
| Jun 06 2018 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 51.77 | 15,000 | 776,550 | 16,750 | 1.8 K to 16.8 K (+857.14 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 4,895 | 0 | 48,972 | 44.1 K to 49 K (+11.11 %) |
| Jun 30 2017 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 132.30 | 4,210 | 556,983 | 4,210 | |
| Jun 30 2017 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 1,620 | 0 | 1,620 | |
| Jun 22 2017 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 0.00 | 1,750 | 0 | 0 | |
| Jun 22 2017 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 0.00 | 1,750 | 0 | 1,750 | 0 to 1.8 K |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 18.64 | 905 | 16,869 | 10,305 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 13.00 | 693 | 9,009 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 13.37 | 693 | 9,265 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 20.08 | 693 | 13,915 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 14.71 | 693 | 10,194 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 8,259 | 0 | 40,077 | 31.8 K to 40.1 K (+25.96 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 577 | 0 | 35,818 | 35.2 K to 35.8 K (+1.64 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 604 | 0 | 35,241 | 34.6 K to 35.2 K (+1.74 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 152 | 0 | 34,637 | 34.5 K to 34.6 K (+0.44 %) |
| Jun 23 2016 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | |
| Jun 23 2016 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 101.80 | 5,000 | 509,000 | 5,000 | |
| May 23 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 5,985 | 0 | 34,485 | 28.5 K to 34.5 K (+21.00 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 11.67 | 21,600 | 252,072 | 0 | |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.76 | 21,600 | 189,216 | 0 | |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.43 | 4,131 | 34,824 | 0 | |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.43 | 300 | 2,529 | 4,131 | |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.28 | 21,600 | 848,448 | 28,500 | 50.1 K to 28.5 K (-43.11 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 11.67 | 21,600 | 252,072 | 50,100 | 28.5 K to 50.1 K (+75.79 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | S | 39.19 | 21,600 | 846,504 | 28,500 | 6.9 K to 28.5 K (+313.04 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.76 | 21,600 | 189,216 | 50,100 | 28.5 K to 50.1 K (+75.79 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.00 | 4,131 | 161,109 | 28,500 | 32.6 K to 28.5 K (-12.66 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.43 | 4,131 | 34,824 | 32,631 | 28.5 K to 32.6 K (+14.49 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.00 | 300 | 11,700 | 28,500 | 28.8 K to 28.5 K (-1.04 %) |
| May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.43 | 300 | 2,529 | 28,800 | 28.5 K to 28.8 K (+1.05 %) |
| May 13 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.43 | 9,969 | 84,039 | 4,431 | |
| May 13 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.25 | 9,969 | 391,283 | 28,500 | 38.5 K to 28.5 K (-25.91 %) |
| May 13 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.43 | 9,969 | 84,039 | 38,469 | 28.5 K to 38.5 K (+34.98 %) |
| Apr 04 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 124 | 0 | 10,811 | |
| Mar 07 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 1,103 | 0 | 14,096 | 13 K to 14.1 K (+8.49 %) |
| Mar 03 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | M | 59.89 | 7,898 | 473,011 | 0 | |
| Mar 03 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 168.63 | 7,898 | 1,331,840 | 12,993 | 20.9 K to 13 K (-37.81 %) |
| Mar 03 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Buy | M | 59.89 | 7,898 | 473,011 | 20,891 | 13 K to 20.9 K (+60.79 %) |
| Mar 03 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 168.50 | 3,837 | 646,535 | 12,993 | 16.8 K to 13 K (-22.80 %) |
| Mar 03 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 168.93 | 633 | 106,933 | 16,830 | 17.5 K to 16.8 K (-3.62 %) |
| Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 14,879 | 152,956 | 0 | |
| Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 34.03 | 14,879 | 506,332 | 28,500 | 43.4 K to 28.5 K (-34.30 %) |
| Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 14,879 | 152,956 | 43,379 | 28.5 K to 43.4 K (+52.21 %) |
| Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 14,820 | 152,350 | 14,879 | |
| Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 35.34 | 14,820 | 523,739 | 28,500 | 43.3 K to 28.5 K (-34.21 %) |
| Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 14,820 | 152,350 | 43,320 | 28.5 K to 43.3 K (+52.00 %) |
| Jan 04 2016 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 101 | 0 | 10,684 | |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | M | 51.23 | 7,540 | 386,274 | 0 | |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | M | 47.31 | 6,137 | 290,341 | 0 | |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 154.48 | 704 | 108,754 | 17,463 | 18.2 K to 17.5 K (-3.88 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 153.89 | 1,241 | 190,977 | 18,167 | 19.4 K to 18.2 K (-6.39 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 154.57 | 2,300 | 355,511 | 19,408 | 21.7 K to 19.4 K (-10.60 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 153.94 | 5,240 | 806,646 | 21,708 | 26.9 K to 21.7 K (-19.44 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Buy | M | 51.23 | 7,540 | 386,274 | 26,948 | 19.4 K to 26.9 K (+38.85 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 154.58 | 1,700 | 262,786 | 19,408 | 21.1 K to 19.4 K (-8.05 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Sell | S | 153.95 | 4,437 | 683,076 | 21,108 | 25.5 K to 21.1 K (-17.37 %) |
| Nov 19 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Buy | M | 47.31 | 6,137 | 290,341 | 25,545 | 19.4 K to 25.5 K (+31.62 %) |
| Oct 01 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 135 | 0 | 10,600 | |
| Jul 02 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 126 | 0 | 10,455 | |
| Jun 29 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 175.27 | 15,000 | 2,629,050 | 15,000 | |
| Jun 22 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 30.75 | 15,000 | 461,250 | 15,000 | |
| Jun 22 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 41.14 | 30,000 | 1,234,200 | 0 | |
| Jun 22 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | S | 185.60 | 15,000 | 2,783,973 | 0 | 15 K to 0 (-100.00 %) |
| Jun 22 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 30.75 | 15,000 | 461,250 | 15,000 | 0 to 15 K |
| Jun 22 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 185.78 | 30,000 | 5,573,400 | 0 | 30 K to 0 (-100.00 %) |
| Jun 22 2015 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 41.14 | 30,000 | 1,234,200 | 30,000 | 0 to 30 K |
| Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 13,457 | 138,338 | 29,699 | |
| Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 31.33 | 13,457 | 421,541 | 28,500 | 42 K to 28.5 K (-32.07 %) |
| Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 13,457 | 138,338 | 41,957 | 28.5 K to 42 K (+47.22 %) |
| May 21 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 9,400 | 0 | 28,500 | 19.1 K to 28.5 K (+49.21 %) |
| Apr 01 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Option Exercise | A | 0.00 | 118 | 0 | 10,331 | |
| Mar 31 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 138.80 | 390 | 54,132 | 19,408 | 19.8 K to 19.4 K (-1.97 %) |
| Mar 10 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 138.97 | 667 | 92,693 | 19,798 | 20.5 K to 19.8 K (-3.26 %) |
| Mar 04 2015 | HSIC | HENRY SCHEIN INC | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 1,317 | 0 | 20,465 | 19.1 K to 20.5 K (+6.88 %) |